VABREPTA Trademark

Trademark Overview

On Wednesday, May 27, 2015, a trademark application was filed for VABREPTA with the United States Patent and Trademark Office. The USPTO has given the VABREPTA trademark a serial number of 86641996. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 13, 2019. This trademark is owned by Glaxo Group Limited. The VABREPTA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
vabrepta

General Information

Serial Number86641996
Word MarkVABREPTA
Filing DateWednesday, May 27, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 13, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 16, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe word(s) "VABREPTA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 2, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Monday, December 9, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 9, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, May 13, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 13, 2019ABANDONMENT - NO USE STATEMENT FILED
Tuesday, October 16, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 15, 2018EXTENSION 5 GRANTED
Wednesday, October 3, 2018EXTENSION 5 FILED
Thursday, October 11, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 3, 2018TEAS EXTENSION RECEIVED
Tuesday, April 10, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 6, 2018EXTENSION 4 GRANTED
Friday, April 6, 2018EXTENSION 4 FILED
Friday, April 6, 2018TEAS EXTENSION RECEIVED
Friday, September 29, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 27, 2017EXTENSION 3 GRANTED
Wednesday, September 27, 2017EXTENSION 3 FILED
Wednesday, September 27, 2017TEAS EXTENSION RECEIVED
Tuesday, April 11, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 7, 2017EXTENSION 2 GRANTED
Friday, April 7, 2017EXTENSION 2 FILED
Friday, April 7, 2017TEAS EXTENSION RECEIVED
Wednesday, September 14, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 12, 2016EXTENSION 1 GRANTED
Monday, September 12, 2016EXTENSION 1 FILED
Monday, September 12, 2016TEAS EXTENSION RECEIVED
Tuesday, April 12, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 16, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 16, 2016PUBLISHED FOR OPPOSITION
Wednesday, January 27, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 13, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, January 6, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 18, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 18, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 16, 2015ASSIGNED TO LIE
Wednesday, December 2, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 9, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 9, 2015NON-FINAL ACTION E-MAILED
Wednesday, September 9, 2015NON-FINAL ACTION WRITTEN
Tuesday, September 8, 2015ASSIGNED TO EXAMINER
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 2, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, May 30, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

vabrepta pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological